Table 5. Lysophospholipids of dogs after consuming control* or treatment foods for 194 days.† .
Control Food | Increased (n-3) FA Food | Increased(n-3) and (n-6)FA Food | Two-way ANOVA Analysis(P values) | |||
Number of Animals, N | 13 | 12 | 13 | Diet Main Effect | Time Main Effect | Diet by Time Main Effect |
Added Fish Oil, % | 0 | 0.6 | 1.5 | |||
Added L-carnitine, mg/kg | 0 | 300 | 300 | |||
Added Coconut and Corn Oils, Reduced Animal Fat (+,–) | – | – | + | |||
1-linoleoyl-glycerophosphoethanolamine | 0.81 | 0.72a | 0.98 | <0.05 | ||
2-linoleoyl-glycerophosphoethanolamine | 0.87a | 0.85b | 0.97 | <0.05 | <0.05 | |
1-arachidonoyl-glycerophosphoethanolamine | 0.96 | 0.78b | 0.65a | <0.05 | <0.05 | |
2-arachidonoyl-glycerophosphoethanolamine | 0.85 | 0.76b | 0.92 | <0.05 | <0.10 | |
1-arachidonoyl-glycerophosphocholine | 1.75 | 0.96 | 1.06 | |||
2-arachidonoyl-glycerophosphocholine | 1.80 | 2.05 | 0.81 | |||
1-docosahexaenoyl-glycerophosphocholine | 1.73b | 3.77a | 2.79a | <0.05 | <0.05 |
PrescriptionDiet® k/d®, Hill’s Pet Nutrition, Inc.
Using serum values from baseline, each animal served as its own control. Data are presented relative to baseline as fold change. All data were log-transformed prior to statistical analysis.
Indicates significantly increased or decreased fold-change between the diet group shown and baseline at P<0.05.
Indicates fold-change values that are trends but missed the significant cutoff (P>0.05, P<0.10).